GENINUS Inc. (KOSDAQ:389030)
South Korea · Delayed Price · Currency is KRW 2,040.00
-15.00 (-0.73%)
At close: Jul 21, 2026
GENINUS Market Cap
GENINUS has a market cap or net worth of 80.36 billion as of July 21, 2026. Its market cap has increased by 13.65% in one year.
Market Cap
80.36B
Enterprise Value
60.61B
Revenue
10.24B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,040.00
ChartMarket Cap Chart
Since November 8, 2021, GENINUS's market cap has decreased from 145.65B to 80.36B, a decrease of -44.83%. That is a compound annual growth rate of -11.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 80.36B | -31.16% |
| Dec 30, 2025 | 116.73B | 154.55% |
| Dec 30, 2024 | 45.86B | -47.60% |
| Dec 28, 2023 | 87.52B | 25.13% |
| Dec 29, 2022 | 69.94B | -49.53% |
| Dec 30, 2021 | 138.58B | -4.85% |
| Nov 8, 2021 | 145.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 210.64B |
| 3billion | 171.52B |
| Cytogen | 67.94B |
| Protia | 63.18B |
| GC Medical Science | 57.18B |
| Inventera | 55.53B |
| HLB Panagene | 48.44B |
| Seoulin Bioscience | 39.33B |